These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 24912471

  • 1. MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
    Simioni S, Amarù F, Bonnier G, Kober T, Rotzinger D, Du Pasquier R, Schluep M, Meuli R, Sbarbati A, Thiran JP, Krueger G, Granziera C.
    J Neurol; 2014 Aug; 261(8):1606-13. PubMed ID: 24912471
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R, Bisecco A, Corbo D, Della Corte M, d'Ambrosio A, Docimo R, Gallo A, Esposito F, Esposito S, Cirillo M, Lavorgna L, Tedeschi G, Bonavita S.
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [Abstract] [Full Text] [Related]

  • 3. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Jul; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP, Kincal M, Vitorino R, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP, Pimentel-Silva LR, Damasceno BP, Damasceno A.
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [Abstract] [Full Text] [Related]

  • 8. Quantitative T1 brain mapping in early relapsing-remitting multiple sclerosis: longitudinal changes, lesion heterogeneity and disability.
    Harper JG, York EN, Meijboom R, Kampaite A, Thrippleton MJ, Kearns PKA, Valdés Hernández MDC, Chandran S, Waldman AD, FutureMS consortium.
    Eur Radiol; 2024 Jun; 34(6):3826-3839. PubMed ID: 37943312
    [Abstract] [Full Text] [Related]

  • 9. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
    Rovaris M, Iannucci G, Falautano M, Possa F, Martinelli V, Comi G, Filippi M.
    J Neurol Sci; 2002 Mar 30; 195(2):103-9. PubMed ID: 11897239
    [Abstract] [Full Text] [Related]

  • 10. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 30; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 11. An Ultra-High Field Study of Cerebellar Pathology in Early Relapsing-Remitting Multiple Sclerosis Using MP2RAGE.
    Fartaria MJ, OʼBrien K, Şorega A, Bonnier G, Roche A, Falkovskiy P, Krueger G, Kober T, Bach Cuadra M, Granziera C.
    Invest Radiol; 2017 May 30; 52(5):265-273. PubMed ID: 27898603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fluid and White Matter Suppression: New Sensitive 3 T Magnetic Resonance Imaging Contrasts for Cortical Lesion Detection in Multiple Sclerosis.
    Müller J, La Rosa F, Beaumont J, Tsagkas C, Rahmanzadeh R, Weigel M, Bach Cuadra M, Gambarota G, Granziera C.
    Invest Radiol; 2022 Sep 01; 57(9):592-600. PubMed ID: 35510874
    [Abstract] [Full Text] [Related]

  • 14. Periventricular gradient of T1 tissue alterations in multiple sclerosis.
    Vaneckova M, Piredda GF, Andelova M, Krasensky J, Uher T, Srpova B, Havrdova EK, Vodehnalova K, Horakova D, Hilbert T, Maréchal B, Fartaria MJ, Ravano V, Kober T.
    Neuroimage Clin; 2022 Sep 01; 34():103009. PubMed ID: 35561554
    [Abstract] [Full Text] [Related]

  • 15. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.
    Neuroradiology; 2017 Aug 01; 59(8):771-780. PubMed ID: 28623483
    [Abstract] [Full Text] [Related]

  • 16. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N.
    Arch Neurol; 2007 Aug 01; 64(8):1157-61. PubMed ID: 17698706
    [Abstract] [Full Text] [Related]

  • 17. Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis.
    Zhao L, Ng A, Chen Q, Lam B, Abrigo J, Au C, Mok VCT, Wong A, Lau AY.
    Ann Clin Transl Neurol; 2020 Jul 01; 7(7):1193-1203. PubMed ID: 32519512
    [Abstract] [Full Text] [Related]

  • 18. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
    Portaccio E, Amato MP, Bartolozzi ML, Zipoli V, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N.
    J Neurol Sci; 2006 Jun 15; 245(1-2):195-9. PubMed ID: 16631794
    [Abstract] [Full Text] [Related]

  • 19. 7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis.
    Spini M, Choi S, Harrison DM.
    J Neuroimaging; 2020 Jul 15; 30(4):531-536. PubMed ID: 32569408
    [Abstract] [Full Text] [Related]

  • 20. Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients.
    Nowaczyk N, Kalinowska-Łyszczarz A, Paprzycki W, Michalak S, Kaźmierski R, Pawlak MA.
    Neurol Neurochir Pol; 2019 Jul 15; 53(1):18-25. PubMed ID: 30742302
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.